Chronic Lymphocytic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2008-02-11
Clinical Trial Update: This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL) [Phase 3]
A Phase 3 trial evaluating oblimersen (Genasense) in combination with rituximab and fludarabine for previously untreated chronic lymphocytic…